We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+23.79%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$340M
AUM Growth
-$5.31M
Cap. Flow
-$28M
Cap. Flow %
-8.22%
Top 10 Hldgs %
23.05%
Holding
889
New
138
Increased
211
Reduced
255
Closed
64

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$10.1M
2
VALE icon
Vale
VALE
+$2.39M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.33M
4
KO icon
Coca-Cola
KO
+$2.2M
5
WFC icon
Wells Fargo
WFC
+$1.58M

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.54%
2 Consumer Discretionary 15.45%
3 Healthcare 13.48%
4 Technology 13.47%
5 Financials 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGT icon
276
Vanguard Information Technology ETF
VGT
$146B
$248K 0.07%
+5,600
New +$230K
APD icon
277
Air Products & Chemicals
APD
$64.7B
$246K 0.07%
+899
New +$253K
EW icon
278
Edwards Lifesciences
EW
$49.4B
$245K 0.07%
2,682
-2,496
-48% -$207K
VAC icon
279
Marriott Vacations Worldwide
VAC
$3.48B
$245K 0.07%
1,783
+59
+3% +$6.96K
FSLY icon
280
Fastly Inc
FSLY
$3.87B
$245K 0.07%
+2,800
New +$247K
DAL icon
281
Delta Air Lines
DAL
$51.9B
$244K 0.07%
6,058
+1,244
+26% +$45.2K
SHAK icon
282
Shake Shack
SHAK
$2.35B
$242K 0.07%
2,854
+1,614
+130% +$125K
WKHS icon
283
Workhorse Group
WKHS
$33.3M
$239K 0.07%
+4
New +$260K
VG
284
DELISTED
Vonage Holdings Corporation
VG
$238K 0.07%
18,524
+10,232
+123% +$125K
MCK icon
285
McKesson
MCK
$105B
$236K 0.07%
1,357
-5,368
-80% -$894K
LUV icon
286
Southwest Airlines
LUV
$19.2B
$236K 0.07%
5,060
+2,816
+125% +$122K
RCL icon
287
Royal Caribbean
RCL
$66.7B
$235K 0.07%
3,144
+221
+8% +$15.4K
APTV icon
288
Aptiv
APTV
$9.08B
$233K 0.07%
1,788
+88
+5% +$9.78K
FROG icon
289
JFrog
FROG
$11.7B
$232K 0.07%
+3,692
New +$257K
PDD icon
290
Pinduoduo
PDD
$111B
$231K 0.07%
1,300
-3,388
-72% -$405K
ALXN
291
DELISTED
Alexion Pharmaceuticals
ALXN
$230K 0.07%
1,472
+306
+26% +$39.3K
LIN icon
292
CALL
Linde
LIN
$213B
$225K 0.07%
126
-351
-74% -$86.1K
SWCH
293
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$225K 0.07%
13,733
+8,250
+150% +$129K
EMR icon
294
Emerson Electric
EMR
$82B
$223K 0.07%
2,777
-15,265
-85% -$1.13M
AEP icon
295
American Electric Power
AEP
$65.7B
$223K 0.07%
2,677
-926
-26% -$80.4K
AYX
296
DELISTED
Alteryx Inc
AYX
$223K 0.07%
1,830
-420
-19% -$52.9K
PII icon
297
Polaris
PII
$3.29B
$222K 0.07%
2,333
+765
+49% +$73.2K
JBHT icon
298
JB Hunt Transport Services
JBHT
$25.6B
$222K 0.07%
1,626
+975
+150% +$129K
MDC
299
DELISTED
M.D.C. Holdings, Inc.
MDC
$221K 0.06%
4,902
+2,953
+152% +$132K
LEU icon
300
Centrus Energy
LEU
$2.91B
$217K 0.06%
+9,397
New +$131K

Similar funds

Exane Derivatives's Q4 2020 Portfolio in Review

As of Q4 2020, Exane Derivatives held 889 positions worth $340M, down 1.5% from $345M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Exane Derivatives withdrew a net $28M in Q4 2020, closing 64 positions and reducing 255 holdings. Its most notable exit was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $2.55M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Exane Derivatives opened a new position in Vale worth $3.01M.

  • Exane Derivatives's largest Q4 2020 buy was Vale: 179,430 shares worth $3.01M.
  • Exane Derivatives added most to Stellantis in Q4 2020, an estimated $10.1M increase.
  • Exane Derivatives's biggest Q4 2020 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $13.6M.
  • Exane Derivatives fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q4 2020, selling an estimated $2.55M.
  • Exane Derivatives's ten largest holdings make up 23% of its $340M portfolio in Q4 2020.
  • Exane Derivatives opened 138 new positions and closed 64 in Q4 2020.
  • Exane Derivatives's portfolio value fell 1.5% quarter-over-quarter to $340M.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.